Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: A randomized trial

Annals of Internal Medicine

Volumn 168, Issue 11, 2018, Pages 775-782

  Holme, Øyvind ^a,k   Løberg, Magnus ^a   Kalager, Mette ^a   Bretthauer, Michael ^a,d   Hernán, Miguel A ^c   Aas, Eline ^a   Eide, Tor J ^d   Skovlund, Eva ^e   Lekven, Jon ^f   Schneede, Jörn ^g   Tveit, Kjell Magne ^d   Vatn, Morten ^a,d   Ursin, Giske ^a,b,m   Hoff, Geir ^b,j   Efskind, Per ^h   Gondal, Ghous ⁱ   Huppertz Hauss, Gert ^j   Hofstad, Bjørn ^d   Holmsen, Solveig Thorp ^d   Larsen, Inger Kristin ^b   Moritz, Volker ^j   Nyhus, Sverre ^l   Thiis Evensen, Espen ^d   Grotmol, Tom ^b   Iversen, Tor ^a   more..

^a UNIVERSITY OF OSLO   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g UMEÅ UNIVERSITY   (Sweden)

^h Nedre Glommen Physicians   (Norway)

ⁱ Østfold Hospital   (Norway)

^j TELEMARK HOSPITAL   (Norway)

^k Sørlandet Hospital   (Norway)

^l VESTFOLD HOSPITAL TRUST   (Norway)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALL CAUSE MORTALITY; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NORWAY; NORWEGIAN (PEOPLE); OCCULT BLOOD TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SIGMOIDOSCOPY; CAUSE OF DEATH; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; INCIDENCE; MASS SCREENING; MORTALITY; OCCULT BLOOD; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK REDUCTION; SEX FACTOR;

CAUSE OF DEATH; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; NORWAY; OCCULT BLOOD; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK REDUCTION BEHAVIOR; SEX FACTORS; SIGMOIDOSCOPY;

EID: 85046024591     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-1441     Document Type: Article

References (20)

1. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garciá FAR, et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564-75. [PMID: 27304597] doi:10.1001/jama.2016.5989
2. Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017;389:1299-1311. [PMID: 28236467] doi:10.1016/S0140-6736(17)30396-3
3. Holme O, Loberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312: 606-15. [PMID: 25117129] doi:10.1001/jama.2014.8266
4. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-57. [PMID: 22612596] doi:10.1056/NEJMoa 1114635
5. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al; SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst. 2011;103:1310-22. [PMID: 21852264] doi:10.1093/jnci/djr284
6. Holme O, Schoen RE, Senore C, Segnan N, Hoff G, Loberg M, et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ. 2017;356:i6673. [PMID: 28087510] doi:10.1136/bmj.i6673
7. Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol. 2002;37:568-73. [PMID: 12059059]
8. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol. 2003;38:635-42. [PMID: 12825872]
9. Hoff G, Sauar J, Hofstad B, Vatn MH. The Norwegian guidelines for surveillance after polypectomy: 10-year intervals. Scand J Gastroenterol. 1996;31:834-6. [PMID: 8888428]
10. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624-33. [PMID: 20430429] doi:10.1016/S0140-6736(10)60551-X
11. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol. 2011;174:1140-6. [PMID: 21984657] doi:10.1093/aje/kwr188
12. Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex-and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21:5167-75. [PMID: 25954090] doi:10.3748/wjg.v21.i17.5167
13. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106-14. [PMID: 24047060] doi:10.1056/NEJMoa1300720
14. Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, et al; CONCeRN Study Investigators. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005; 352:2061-8. [PMID: 15901859]
15. Robertson DJ, Kaminski MF, Bretthauer M. Effectiveness, training and quality assurance of colonoscopy screening for colorectal cancer. Gut. 2015;64:982-90. [PMID: 25804631] doi:10.1136/gutjnl-2014-308076
16. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007:CD001216. [PMID: 17253456]
17. Swartz AW, Eberth JM, Josey MJ, Strayer SM. Reanalysis of allcause mortality in the U.S. Preventive Services Task Force 2016 evidence report on colorectal cancer screening. Ann Intern Med. 2017; 167:602-3. [PMID: 28828493] doi:10.7326/M17-0859
18. Robb KA, Lo SH, Power E, Kralj-Hans I, Edwards R, Vance M, et al. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK. J Med Screen. 2012;19:171-6. [PMID: 23486697] doi:10.1258/jms.2012.012129
19. Larsen IK, Grotmol T, Bretthauer M, Gondal G, Huppertz-Hauss G, Hofstad B, et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scand J Gastroenterol. 2002;37:850-5. [PMID: 12190102]
20. Senore C, Ederle A, Fantin A, Andreoni B, Bisanti L, Grazzini G, et al. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting. J Med Screen. 2011;18:128-34. [PMID: 22045821] doi:10.1258/jms.2011.010135